Fueling the future by investing in science's boldest breakthroughs.
Empirical Ventures is a specialist VC and venture builder backing the best early-stage deep-tech and life-science companies in the world, solving real problems and built by the scientists behind the research.
We invest in scientific breakthroughs that advance human capability and create returns.
Our planet faces urgent challenges, from climate change and resource scarcity to the need for accessible healthcare. At the intersection of those pressures lies immense potential. By backing pioneering science, we unlock solutions that address global challenges while disrupting existing markets and creating new ones.
- 01
Entirely new technologies
Developed from fundamental research, not incremental iteration on what already exists.
- 02
IP-rich, defensible innovation
Deep technical moats and competitive defensibility that compound over time.
- 03
Solutions to real problems
Across life sciences, advanced materials, TechBio, photonics and quantum, robotics, AgTech and deep tech.
- 04
Validated by world-leading domain experts
Every opportunity is pressure-tested by scientists at the frontier of their field, so we can price the risk others can't and back the science they miss.
The epicentre of deep tech.
From mitochondrial medicine to solvent-free batteries, we back founders turning breakthrough research into ventures that matter. Here is a selection.
We back the science, then help the world see it.
Empirical Ventures is run by its two founding partners, Dr Ben Miles and Dr Johnathan Matlock, scientists and company-builders who work hands-on with the companies they back. We understand the research well enough to price the risk before the market does.
And because Ben reaches a global science audience of more than three million, the companies we back gain something most funds can't offer: distribution for their story, a magnet for technical talent, and a direct line to the people who care about the science.
Meet the team →
Dr Ben Miles, General Partner
Deep tech, at the cutting edge.
Every week, Dr Ben Miles decodes the breakthroughs reshaping the world, from fusion reactors to impossible chips, for a global audience of more than three million. A few of the latest.
Back the ventures that matter, or bring us yours.
Whether you are an investor seeking exposure to deep tech or a founder with breakthrough IP, there is a place for you here.